Challenges and discoveries in polypharmacology of neurodegenerative diseases

TCM Lustoza Rodrigues, NF de Sousa… - Current Topics in …, 2023 - ingentaconnect.com
Background: Neurological disorders are composed of several diseases that affect the central
and peripheral nervous system; among these are neurodegenerative diseases, which lead …

[HTML][HTML] Pharmacogenomics—a New Frontier for Individualized Treatment of Parkinson's Disease

JS Liu, Y Chen, DD Shi, BR Zhang… - Current …, 2023 - ncbi.nlm.nih.gov
Background Parkinson's disease (PD) is the second most common neurodegenerative
disease with a significant public health burden. It is characterized by the gradual …

Genetic risk variants in New Yorkers of Puerto Rican and Dominican Republic heritage with Parkinson's disease

G Miltenberger-Miltenyi, RA Ortega, A Domingo… - npj Parkinson's …, 2023 - nature.com
There is a paucity of genetic characterization in people with Parkinson's disease (PD) of
Latino and Afro-Caribbean descent. Screening LRRK2 and GBA variants in 32 New Yorkers …

An update on the pharmacogenetic considerations when prescribing dopamine receptor agonists for Parkinson's disease

P Ayuso, FJ Jiménez-Jiménez… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Parkinson's disease is a chronic neurodegenerative multisystemic disorder that
affects approximately 2% of the population over 65 years old. This disorder is characterized …

Molecular Mechanics Demonstrate S-COMT as promising therapeutic receptor when analyzed with secondary plant metabolites.

D Garg, A Vashishth, MJ Jayawant… - Journal of the Indian …, 2024 - Elsevier
Major depressive disorder (MDD) and other psychiatric conditions are debilitating illnesses
affecting millions globally. Catechol-O-methyltransferase (COMT), an enzyme that regulates …

Plant-Derived Natural Products Targeting Multiple Pathways as Potential Therapeutics in the Treatment of Parkinson's Disease

A Vijay, A Balakrishnan - Evidence-based Functional Foods for Prevention …, 2023 - Springer
Parkinson's disease (PD) is a chronic neurodegenerative disorder (ND) characterised by
gradual degradation of dopaminergic neurons in the substantia nigra pars compacta (SNpc) …

The use of Nicotinamide in Parkinson's disease; A Possible path to the future. Review Article

SF Fahmy, M Alshahawy, N Mohamed… - … Sciences Ain Shams …, 2023 - aps.journals.ekb.eg
Increasing the prevalence of Parkinson's disease is an alarming sign that needs attention,
so focusing on new medications and regimens which play an important role in prevention …

The Relationship Between COMT and MAO-B Gene Polymorphisms with Levodopa in Parkinson's Disease Patients; A Review

VL Hasna, A Kasasiah, RT Manalu… - … DAN BIOLOGI NUKLEUS …, 2024 - jurnal.ulb.ac.id
Parkinson's disease is a degenerative nervous system disorder caused by the death of
dopamine-producing cells in the substantia nigra. Dopaminergic treatment could alleviate …

The effect of variations in GRIN genes on the biogenesis and functional properties of the NMDA receptor

V Kuchtiak - 2024 - dspace.cuni.cz
The expression and activity of ionotropic glutamate receptors control signal transduction at
the excitatory synapses in the central nervous system. The major class are the calcium …

[PDF][PDF] PHARMACOGENOMICS IN NEUROLOGY

SA Sintila, C Bakirtzis, I Nikolaidis… - Αρχεία Κλινικής …, 2022 - jneurology.gr
Precision medicine is an emerging medical approach which aims to individualize therapies
in patients with complex, multifactorial disease in order to increase drug effectiveness and …